nodes	percent_of_prediction	percent_of_DWPC	metapath
MACITENTAN—ALB—Fluorouracil—head and neck cancer	0.3	0.654	CbGbCtD
MACITENTAN—CYP3A4—Vinblastine—head and neck cancer	0.087	0.19	CbGbCtD
MACITENTAN—CYP3A4—Docetaxel—head and neck cancer	0.0717	0.157	CbGbCtD
MACITENTAN—EDNRA—EGFR-dependent Endothelin signaling events—EGFR—head and neck cancer	0.0177	0.0371	CbGpPWpGaD
MACITENTAN—EDNRA—EGFR-dependent Endothelin signaling events—HRAS—head and neck cancer	0.0142	0.0298	CbGpPWpGaD
MACITENTAN—EDNRB—Prostaglandin Synthesis and Regulation—PTGS2—head and neck cancer	0.0133	0.0279	CbGpPWpGaD
MACITENTAN—EDNRB—G alpha (q) signalling events—KISS1—head and neck cancer	0.013	0.0273	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—KISS1—head and neck cancer	0.0129	0.0269	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—KISS1—head and neck cancer	0.0117	0.0244	CbGpPWpGaD
MACITENTAN—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.0109	0.0228	CbGpPWpGaD
MACITENTAN—EDNRB—G alpha (q) signalling events—GRP—head and neck cancer	0.0107	0.0224	CbGpPWpGaD
MACITENTAN—EDNRB—Peptide ligand-binding receptors—GRP—head and neck cancer	0.0106	0.0222	CbGpPWpGaD
MACITENTAN—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.00992	0.0208	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—GRP—head and neck cancer	0.00959	0.0201	CbGpPWpGaD
MACITENTAN—EDNRA—Prostaglandin Synthesis and Regulation—PTGS2—head and neck cancer	0.00954	0.02	CbGpPWpGaD
MACITENTAN—EDNRA—G alpha (q) signalling events—KISS1—head and neck cancer	0.00932	0.0195	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—KISS1—head and neck cancer	0.00921	0.0193	CbGpPWpGaD
MACITENTAN—EDNRB—Endothelin Pathways—MAPK1—head and neck cancer	0.00876	0.0183	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.00863	0.018	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—KISS1—head and neck cancer	0.00834	0.0174	CbGpPWpGaD
MACITENTAN—ALB—FOXA2 and FOXA3 transcription factor networks—CEBPA—head and neck cancer	0.0078	0.0163	CbGpPWpGaD
MACITENTAN—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.00769	0.0161	CbGpPWpGaD
MACITENTAN—EDNRA—G alpha (q) signalling events—GRP—head and neck cancer	0.00768	0.0161	CbGpPWpGaD
MACITENTAN—EDNRA—Peptide ligand-binding receptors—GRP—head and neck cancer	0.00758	0.0159	CbGpPWpGaD
MACITENTAN—EDNRB—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.0071	0.0149	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—GRP—head and neck cancer	0.00687	0.0144	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—KISS1—head and neck cancer	0.00657	0.0137	CbGpPWpGaD
MACITENTAN—Hepatotoxicity—Hydroxyurea—head and neck cancer	0.00638	0.1	CcSEcCtD
MACITENTAN—EDNRA—Endothelin Pathways—MAPK1—head and neck cancer	0.00627	0.0131	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—KISS1—head and neck cancer	0.00617	0.0129	CbGpPWpGaD
MACITENTAN—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.00596	0.0125	CbGpPWpGaD
MACITENTAN—EDNRB—Endothelins—MAPK3—head and neck cancer	0.00549	0.0115	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR ligand binding—GRP—head and neck cancer	0.00541	0.0113	CbGpPWpGaD
MACITENTAN—CYP2C19—Xenobiotics—CYP1A1—head and neck cancer	0.00524	0.011	CbGpPWpGaD
MACITENTAN—EDNRB—Endothelins—MAPK1—head and neck cancer	0.00522	0.0109	CbGpPWpGaD
MACITENTAN—EDNRA—Class A/1 (Rhodopsin-like receptors)—GRP—head and neck cancer	0.00508	0.0106	CbGpPWpGaD
MACITENTAN—CYP2C19—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00504	0.0105	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—KISS1—head and neck cancer	0.0047	0.00984	CbGpPWpGaD
MACITENTAN—EDNRB—Endothelins—HRAS—head and neck cancer	0.00419	0.00877	CbGpPWpGaD
MACITENTAN—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.00402	0.00842	CbGpPWpGaD
MACITENTAN—EDNRA—Endothelins—MAPK3—head and neck cancer	0.00393	0.00822	CbGpPWpGaD
MACITENTAN—CYP2C19—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.00389	0.00814	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR ligand binding—GRP—head and neck cancer	0.00387	0.0081	CbGpPWpGaD
MACITENTAN—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.00376	0.00788	CbGpPWpGaD
MACITENTAN—EDNRA—Endothelins—MAPK1—head and neck cancer	0.00374	0.00782	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—KISS1—head and neck cancer	0.00371	0.00777	CbGpPWpGaD
MACITENTAN—EDNRB—Endothelins—AKT1—head and neck cancer	0.0037	0.00774	CbGpPWpGaD
MACITENTAN—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.00361	0.00756	CbGpPWpGaD
MACITENTAN—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.00343	0.00717	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—KISS1—head and neck cancer	0.00337	0.00705	CbGpPWpGaD
MACITENTAN—Hepatotoxicity—Docetaxel—head and neck cancer	0.00331	0.0522	CcSEcCtD
MACITENTAN—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.00315	0.00659	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—GRP—head and neck cancer	0.00306	0.0064	CbGpPWpGaD
MACITENTAN—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.00303	0.00634	CbGpPWpGaD
MACITENTAN—EDNRA—Endothelins—HRAS—head and neck cancer	0.003	0.00628	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—SOD2—head and neck cancer	0.00292	0.00611	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—GRP—head and neck cancer	0.00278	0.00581	CbGpPWpGaD
MACITENTAN—Infestation—Hydroxyurea—head and neck cancer	0.00276	0.0434	CcSEcCtD
MACITENTAN—Infestation NOS—Hydroxyurea—head and neck cancer	0.00276	0.0434	CcSEcCtD
MACITENTAN—Pharyngitis—Vinblastine—head and neck cancer	0.00269	0.0424	CcSEcCtD
MACITENTAN—EDNRA—GPCR downstream signaling—KISS1—head and neck cancer	0.00266	0.00556	CbGpPWpGaD
MACITENTAN—EDNRA—Endothelins—AKT1—head and neck cancer	0.00265	0.00554	CbGpPWpGaD
MACITENTAN—CYP2C19—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00254	0.00532	CbGpPWpGaD
MACITENTAN—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.00252	0.00526	CbGpPWpGaD
MACITENTAN—Fluid retention—Docetaxel—head and neck cancer	0.00243	0.0382	CcSEcCtD
MACITENTAN—EDNRA—Signaling by GPCR—KISS1—head and neck cancer	0.00241	0.00505	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—SOD2—head and neck cancer	0.00238	0.00497	CbGpPWpGaD
MACITENTAN—Nasopharyngitis—Fluorouracil—head and neck cancer	0.0023	0.0362	CcSEcCtD
MACITENTAN—ALB—Folate Metabolism—GPX1—head and neck cancer	0.00227	0.00474	CbGpPWpGaD
MACITENTAN—Angiopathy—Hydroxyurea—head and neck cancer	0.00224	0.0353	CcSEcCtD
MACITENTAN—EDNRA—GPCR downstream signaling—GRP—head and neck cancer	0.00219	0.00458	CbGpPWpGaD
MACITENTAN—Anaemia—Vinblastine—head and neck cancer	0.00218	0.0343	CcSEcCtD
MACITENTAN—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00217	0.00455	CbGpPWpGaD
MACITENTAN—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00215	0.00449	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.00206	0.0043	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.002	0.00418	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—KISS1—head and neck cancer	0.00199	0.00417	CbGpPWpGaD
MACITENTAN—Anaemia—Hydroxyurea—head and neck cancer	0.00199	0.0313	CcSEcCtD
MACITENTAN—EDNRA—Signaling by GPCR—GRP—head and neck cancer	0.00199	0.00416	CbGpPWpGaD
MACITENTAN—Infestation—Fluorouracil—head and neck cancer	0.00198	0.0312	CcSEcCtD
MACITENTAN—Infestation NOS—Fluorouracil—head and neck cancer	0.00198	0.0312	CcSEcCtD
MACITENTAN—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.00197	0.00413	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.00196	0.00409	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.00196	0.00409	CbGpPWpGaD
MACITENTAN—Urinary tract infection—Fluorouracil—head and neck cancer	0.00193	0.0303	CcSEcCtD
MACITENTAN—EDNRB—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.0019	0.00397	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—SOD2—head and neck cancer	0.00189	0.00395	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—GPX1—head and neck cancer	0.0018	0.00377	CbGpPWpGaD
MACITENTAN—Pharyngitis—Fluorouracil—head and neck cancer	0.00177	0.0278	CcSEcCtD
MACITENTAN—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00176	0.00369	CbGpPWpGaD
MACITENTAN—Oedema—Hydroxyurea—head and neck cancer	0.00176	0.0277	CcSEcCtD
MACITENTAN—Infection—Hydroxyurea—head and neck cancer	0.00175	0.0275	CcSEcCtD
MACITENTAN—Nervous system disorder—Hydroxyurea—head and neck cancer	0.00172	0.0271	CcSEcCtD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.0017	0.00355	CbGpPWpGaD
MACITENTAN—Nasopharyngitis—Docetaxel—head and neck cancer	0.00166	0.0261	CcSEcCtD
MACITENTAN—EDNRB—Signaling Pathways—GRP—head and neck cancer	0.00164	0.00343	CbGpPWpGaD
MACITENTAN—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.00162	0.00338	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—STAT6—head and neck cancer	0.00159	0.00333	CbGpPWpGaD
MACITENTAN—EDNRB—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.00157	0.00328	CbGpPWpGaD
MACITENTAN—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.0015	0.00313	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—head and neck cancer	0.00147	0.00308	CbGpPWpGaD
MACITENTAN—Anaemia—Fluorouracil—head and neck cancer	0.00143	0.0225	CcSEcCtD
MACITENTAN—Infestation NOS—Docetaxel—head and neck cancer	0.00143	0.0225	CcSEcCtD
MACITENTAN—Infestation—Docetaxel—head and neck cancer	0.00143	0.0225	CcSEcCtD
MACITENTAN—EDNRA—Signaling Pathways—KISS1—head and neck cancer	0.00143	0.00298	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—YAP1—head and neck cancer	0.00141	0.00295	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—head and neck cancer	0.0014	0.00293	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—head and neck cancer	0.0014	0.00293	CbGpPWpGaD
MACITENTAN—EDNRA—G alpha (q) signalling events—PIK3CA—head and neck cancer	0.00136	0.00284	CbGpPWpGaD
MACITENTAN—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00131	0.00274	CbGpPWpGaD
MACITENTAN—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00129	0.0027	CbGpPWpGaD
MACITENTAN—Pharyngitis—Docetaxel—head and neck cancer	0.00128	0.0201	CcSEcCtD
MACITENTAN—Oedema—Fluorouracil—head and neck cancer	0.00126	0.0199	CcSEcCtD
MACITENTAN—Infection—Fluorouracil—head and neck cancer	0.00126	0.0198	CcSEcCtD
MACITENTAN—Nervous system disorder—Fluorouracil—head and neck cancer	0.00124	0.0195	CcSEcCtD
MACITENTAN—ALB—Folate Metabolism—IL2—head and neck cancer	0.00124	0.00259	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	0.00121	0.00254	CbGpPWpGaD
MACITENTAN—Headache—Vinblastine—head and neck cancer	0.00121	0.019	CcSEcCtD
MACITENTAN—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.0012	0.00252	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.00119	0.00248	CbGpPWpGaD
MACITENTAN—Hypotension—Fluorouracil—head and neck cancer	0.00118	0.0186	CcSEcCtD
MACITENTAN—EDNRA—Signaling Pathways—GRP—head and neck cancer	0.00117	0.00246	CbGpPWpGaD
MACITENTAN—Angiopathy—Docetaxel—head and neck cancer	0.00117	0.0183	CcSEcCtD
MACITENTAN—EDNRA—Signaling Pathways—STAT6—head and neck cancer	0.00114	0.00238	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	0.00112	0.00235	CbGpPWpGaD
MACITENTAN—Headache—Hydroxyurea—head and neck cancer	0.0011	0.0173	CcSEcCtD
MACITENTAN—ALB—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.00106	0.00222	CbGpPWpGaD
MACITENTAN—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.00106	0.00222	CbGpPWpGaD
MACITENTAN—Anaemia—Docetaxel—head and neck cancer	0.00103	0.0163	CcSEcCtD
MACITENTAN—ALB—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00103	0.00215	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—YAP1—head and neck cancer	0.00101	0.00211	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	0.000988	0.00207	CbGpPWpGaD
MACITENTAN—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	0.000974	0.00204	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	0.000936	0.00196	CbGpPWpGaD
MACITENTAN—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.000928	0.00194	CbGpPWpGaD
MACITENTAN—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000924	0.00193	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—UROD—head and neck cancer	0.000918	0.00192	CbGpPWpGaD
MACITENTAN—Oedema—Docetaxel—head and neck cancer	0.000913	0.0144	CcSEcCtD
MACITENTAN—Infection—Docetaxel—head and neck cancer	0.000907	0.0143	CcSEcCtD
MACITENTAN—ALB—Platelet degranulation—VEGFA—head and neck cancer	0.000901	0.00189	CbGpPWpGaD
MACITENTAN—Nervous system disorder—Docetaxel—head and neck cancer	0.000895	0.0141	CcSEcCtD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—head and neck cancer	0.000859	0.0018	CbGpPWpGaD
MACITENTAN—Hypotension—Docetaxel—head and neck cancer	0.000853	0.0134	CcSEcCtD
MACITENTAN—CYP2C19—Metabolism—UROD—head and neck cancer	0.000824	0.00172	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—IL2—head and neck cancer	0.000815	0.0017	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—TP53—head and neck cancer	0.000794	0.00166	CbGpPWpGaD
MACITENTAN—Headache—Fluorouracil—head and neck cancer	0.000792	0.0125	CcSEcCtD
MACITENTAN—EDNRB—Signaling by GPCR—IL2—head and neck cancer	0.00074	0.00155	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000712	0.00149	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000639	0.00134	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—NOTCH1—head and neck cancer	0.000635	0.00133	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—MAPK3—head and neck cancer	0.000595	0.00124	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	0.000594	0.00124	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	0.000586	0.00123	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—IL2—head and neck cancer	0.000583	0.00122	CbGpPWpGaD
MACITENTAN—Headache—Docetaxel—head and neck cancer	0.000572	0.009	CcSEcCtD
MACITENTAN—EDNRB—Signaling by GPCR—MAPK1—head and neck cancer	0.000566	0.00118	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—EGFR—head and neck cancer	0.000566	0.00118	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	0.000563	0.00118	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000555	0.00116	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000541	0.00113	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—IL2—head and neck cancer	0.00053	0.00111	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—UROD—head and neck cancer	0.000495	0.00104	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—PIK3CA—head and neck cancer	0.000491	0.00103	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—IL2—head and neck cancer	0.00047	0.000984	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—NOTCH1—head and neck cancer	0.000455	0.000951	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—HRAS—head and neck cancer	0.000454	0.000951	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—AKT1—head and neck cancer	0.000442	0.000924	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IL2—head and neck cancer	0.000437	0.000914	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—CCND1—head and neck cancer	0.000426	0.000891	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—MAPK3—head and neck cancer	0.000426	0.000891	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PTEN—head and neck cancer	0.000411	0.00086	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—MAPK1—head and neck cancer	0.000405	0.000847	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—EGFR—head and neck cancer	0.000405	0.000847	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000405	0.000847	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—AKT1—head and neck cancer	0.000401	0.000839	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000401	0.000838	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	0.0004	0.000836	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—PIK3CA—head and neck cancer	0.000387	0.00081	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—NAT2—head and neck cancer	0.000381	0.000797	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	0.000378	0.000791	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—VEGFA—head and neck cancer	0.000371	0.000777	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—STAT3—head and neck cancer	0.000368	0.000769	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000363	0.00076	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	0.00036	0.000753	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.00036	0.000752	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—PIK3CA—head and neck cancer	0.000351	0.000735	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MAPK3—head and neck cancer	0.000351	0.000735	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—NAT2—head and neck cancer	0.000342	0.000716	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—MAPK1—head and neck cancer	0.000334	0.000699	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—EGFR—head and neck cancer	0.000334	0.000699	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—DPYD—head and neck cancer	0.000334	0.000699	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—HRAS—head and neck cancer	0.000325	0.00068	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—YAP1—head and neck cancer	0.000317	0.000663	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—AKT1—head and neck cancer	0.000316	0.000661	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IL2—head and neck cancer	0.000313	0.000654	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	0.000312	0.000653	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—CCND1—head and neck cancer	0.000305	0.000638	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—DPYD—head and neck cancer	0.0003	0.000627	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PTEN—head and neck cancer	0.000294	0.000616	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PIK3CA—head and neck cancer	0.00029	0.000607	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—AKT1—head and neck cancer	0.000287	0.000601	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—YAP1—head and neck cancer	0.000285	0.000595	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TP53—head and neck cancer	0.000281	0.000587	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—HRAS—head and neck cancer	0.000268	0.000562	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—VEGFA—head and neck cancer	0.000266	0.000556	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—STAT3—head and neck cancer	0.000263	0.000551	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	0.000255	0.000534	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MAPK3—head and neck cancer	0.000251	0.000526	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—IL2—head and neck cancer	0.000243	0.000507	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MAPK1—head and neck cancer	0.000239	0.000501	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—EGFR—head and neck cancer	0.000239	0.0005	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000238	0.000498	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—AKT1—head and neck cancer	0.000237	0.000496	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000214	0.000447	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000208	0.000435	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PIK3CA—head and neck cancer	0.000208	0.000434	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—VEGFA—head and neck cancer	0.000206	0.000431	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—NAT2—head and neck cancer	0.000206	0.00043	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TP53—head and neck cancer	0.000201	0.00042	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—MAPK3—head and neck cancer	0.000195	0.000408	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—HRAS—head and neck cancer	0.000192	0.000402	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—TYMS—head and neck cancer	0.00019	0.000398	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GSTM1—head and neck cancer	0.000188	0.000394	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000186	0.00039	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—MAPK1—head and neck cancer	0.000186	0.000388	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—DPYD—head and neck cancer	0.00018	0.000377	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GPX1—head and neck cancer	0.00018	0.000377	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CYP1A1—head and neck cancer	0.000178	0.000373	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—YAP1—head and neck cancer	0.000171	0.000358	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—TYMS—head and neck cancer	0.000171	0.000358	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—AKT1—head and neck cancer	0.00017	0.000355	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GSTM1—head and neck cancer	0.000169	0.000353	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GPX1—head and neck cancer	0.000162	0.000338	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—PIK3CA—head and neck cancer	0.000161	0.000337	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CYP1A1—head and neck cancer	0.00016	0.000335	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—TP53—head and neck cancer	0.000156	0.000326	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—HRAS—head and neck cancer	0.000149	0.000312	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000147	0.000307	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	0.000132	0.000275	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—AKT1—head and neck cancer	0.000132	0.000275	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PTGS2—head and neck cancer	0.000106	0.000222	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—TYMS—head and neck cancer	0.000103	0.000215	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GSTM1—head and neck cancer	0.000102	0.000213	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GPX1—head and neck cancer	9.73e-05	0.000204	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CYP1A1—head and neck cancer	9.63e-05	0.000201	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PTGS2—head and neck cancer	9.52e-05	0.000199	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PTEN—head and neck cancer	9.25e-05	0.000194	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PTEN—head and neck cancer	8.31e-05	0.000174	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PIK3CA—head and neck cancer	6.53e-05	0.000137	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PIK3CA—head and neck cancer	5.86e-05	0.000123	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PTGS2—head and neck cancer	5.73e-05	0.00012	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—AKT1—head and neck cancer	5.33e-05	0.000112	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PTEN—head and neck cancer	4.99e-05	0.000104	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—AKT1—head and neck cancer	4.79e-05	0.0001	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PIK3CA—head and neck cancer	3.52e-05	7.37e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—AKT1—head and neck cancer	2.88e-05	6.02e-05	CbGpPWpGaD
